Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction

Abstract

The recognition of microbial pathogens by the innate immune system involves Toll-like receptors (TLRs), which recognize pathogen-associated molecular patterns1,2,3,4,5,6,7,8,9. Different TLRs recognize different pathogen-associated molecular patterns, with TLR-4 mediating the response to lipopolysaccharide from Gram-negative bacteria5,6,7. All TLRs have a Toll/IL-1 receptor (TIR) domain, which is responsible for signal transduction1,2. MyD88 is one such protein that contains a TIR domain10,11. It acts as an adapter, being involved in TLR-2, TLR-4 and TLR-9 signalling12,13,14,15; however, our understanding of how TLR-4 signals is incomplete15,16. Here we describe a protein, Mal (MyD88-adapter-like), which joins MyD88 as a cytoplasmic TIR-domain-containing protein in the human genome. Mal activates NF-κB, Jun amino-terminal kinase and extracellular signal-regulated kinase-1 and -2. Mal can form homodimers and can also form heterodimers with MyD88. Activation of NF-κB by Mal requires IRAK-2, but not IRAK, whereas MyD88 requires both IRAKs. Mal associates with IRAK-2 by means of its TIR domain. A dominant negative form of Mal inhibits NF-κB, which is activated by TLR-4 or lipopolysaccharide, but it does not inhibit NF-κB activation by IL-1RI or IL-18R. Mal associates with TLR-4. Mal is therefore an adapter in TLR-4 signal transduction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: MyD88-adapter-like (Mal) is a widely expressed homologue of MyD88.
Figure 2: Mal overexpression activated NF-κB, JNK and ERK1/2.
Figure 3: Mal signals by means of MyD88, IRAK-2, TRAF-6 and TAK.
Figure 4: Mal is required for TLR-4 and LPS signalling.

Similar content being viewed by others

References

  1. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394–397 (1997).

    Article  ADS  CAS  Google Scholar 

  2. Rock, F. L., Hardiman, G., Timans, J. C., Kastelein, R. A. & Bazan, J. F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl Acad. Sci. USA 95, 588–593 (1998).

    Article  ADS  CAS  Google Scholar 

  3. Brightbill, H. D. et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285, 732–736 (1999).

    Article  CAS  Google Scholar 

  4. Aliprantis, A. O. et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285, 736–739 (1999).

    Article  CAS  Google Scholar 

  5. Underhill, D. M. et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401, 811–815 (1999).

    Article  ADS  CAS  Google Scholar 

  6. Ozinsky, A. et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl Acad. Sci. USA 97, 13766–13771 (2000).

    Article  ADS  CAS  Google Scholar 

  7. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088 (1998).

    Article  ADS  CAS  Google Scholar 

  8. Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099–1103 (2001).

    Article  ADS  CAS  Google Scholar 

  9. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745 (2000).

    Article  ADS  CAS  Google Scholar 

  10. Muzio, M., Ni, J., Feng, P. & Dixit, V. M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278, 1612–1615 (1997).

    Article  ADS  CAS  PubMed Central  Google Scholar 

  11. Wesche, H., Henzel, W. J., Shillinglaw, W., Li, S. & Cao, Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7, 837–847 (1997).

    Article  CAS  Google Scholar 

  12. Kirschning, C. J., Wesche, H., Merrill Ayres, T. & Rothe, M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188, 2091–2097 (1998).

    Article  CAS  PubMed Central  Google Scholar 

  13. Muzio, M., Natoli, G., Saccani, S., Levrero, M. & Mantovani, A. The human toll signaling pathway: divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187, 2097–2101 (1998).

    Article  CAS  PubMed Central  Google Scholar 

  14. Schnare, M., Holt, A. C., Takeda, K., Akira, S. & Medzhitov, R. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88. Curr. Biol. 10, 1139–1142 (2000).

    Article  CAS  Google Scholar 

  15. Kaisho, T., Takeuchi, O., Kawai, T., Hoshino, K. & Akira, S. Endotoxin-induced maturation of myd88-deficient dendritic cells. J. Immunol. 166, 5688–5694 (2001).

    Article  CAS  Google Scholar 

  16. Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115–122 (1999).

    Article  CAS  Google Scholar 

  17. Cosman, D. et al. Cloning, sequence and expression of human interleukin-2 receptor. Nature 312, 768–771 (1984).

    Article  ADS  CAS  Google Scholar 

  18. Xu, Y. et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408, 111–115 (2000).

    Article  ADS  CAS  Google Scholar 

  19. Jefferies, C. et al. Transactivation by the p65 subunit of NF-κB in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6, and Rac1. Mol. Cell. Biol. 21, 4544–4552 (2001).

    Article  CAS  PubMed Central  Google Scholar 

  20. Schwandner, R., Yamaguchi, K. & Cao, Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J. Exp. Med. 191, 1233–1240 (2000).

    Article  CAS  PubMed Central  Google Scholar 

  21. Yamaguchi, K. et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270, 2008–2011 (1995).

    Article  ADS  CAS  PubMed Central  Google Scholar 

  22. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143–150 (1998).

    Article  CAS  PubMed Central  Google Scholar 

  23. Bowie, A. et al. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl Acad. Sci. USA 97, 10162–10167 (2000).

    Article  ADS  CAS  Google Scholar 

Download references

Acknowledgements

We thank K. Mills for DC samples; M. Muzio for plasmids encoding MyD88, IRAK-2 and TLR-4; E. L. Cooke for plasmids encoding IRAK (1–211); W. Falk for plasmids encoding IL-1R1 and IL-1RacP; and H. Sakurai at Tanabe Seiyaku, Japan, for plasmids encoding TAK-1k63w. We also thank D. Caffrey for advice on alignments, E. Kurt-Jones for HEK293 cells stably transfected with Flag-TLR-4 and CD14, and P. Henneke and D. Golenbock for helpful discussions. This work was supported by the European Union Biomed, Biotech and TMR programmes, Enterprise Ireland and the National Pharmaceutical Biotechnology Centre.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fitzgerald, K., Palsson-McDermott, E., Bowie, A. et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78–83 (2001). https://doi.org/10.1038/35092578

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/35092578

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing